Theodros Asberom

Statistics

Publications

Citations

798

H-Index

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

LabCorp (United States)

Duke University

Theodros Asberom is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1987–2012

Publications

Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

Samuel Chackalamannil, Yan Xia, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2005 · 124 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

A Highly Efficient Total Synthesis of (+)-Himbacine

Samuel Chackalamannil, Robert J. Davies, Theodros Asberom et al. · Journal of the American Chemical Society · 1996 · 85 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7

The chemistry of cyclic vinyl ethers. 6. Total synthesis of polyether ionophore antibiotics of the calcimycin (A-23187) class

Robert K. Boeckman, André B. Charette, Theodros Asberom et al. · Journal of the American Chemical Society · 1991 · 81 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

A convergent general synthetic protocol for construction of spirocyclic ketal ionophores: an application to the total synthesis of (-)-A-23187 (calcimycin)

Robert K. Boeckman, André B. Charette, Theodros Asberom et al. · Journal of the American Chemical Society · 1987 · 75 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

Total Synthesis of (+)-Himbacine and (+)-Himbeline

Samuel Chackalamannil, Robert J. Davies, Yuguang Wang et al. · The Journal of Organic Chemistry · 1999 · 59 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 19